| 1 |
Loh HH, Sukor N. Obstructive sleep apnea and vitamin D level: Has the dust settled? Clin Respir J 2023. [PMID: 36746181 DOI: 10.1111/crj.13593] [Reference Citation Analysis]
|
| 2 |
Abdalbary M, Sobh M, Nagy E, Elnagar S, Elshabrawy N, Shemies R, Abdelsalam M, Asadipooya K, Sabry A, El-Husseini A. Editorial: Management of osteoporosis in patients with chronic kidney disease. Front Med (Lausanne) 2022;9:1032219. [PMID: 36687458 DOI: 10.3389/fmed.2022.1032219] [Reference Citation Analysis]
|
| 3 |
Matias PJ, Laranjinha I, Ávila G, Azevedo A, Jorge C, Ferreira C, Aires I, Amaral T, Gil C, Ferreira A. Long-term cholecalciferol supplementation in hemodialysis patients: Effects on mineral metabolism, inflammation, and cardiac parameters. Semin Dial 2023;36:29-36. [PMID: 35262225 DOI: 10.1111/sdi.13066] [Reference Citation Analysis]
|
| 4 |
Cejka D, Wakolbinger-Habel R, Zitt E, Fahrleitner-Pammer A, Amrein K, Dimai HP, Muschitz C. [Diagnosis and treatment of osteoporosis in patients with chronic kidney disease : Joint guidelines of the Austrian Society for Bone and Mineral Research (ÖGKM), the Austrian Society of Physical and Rehabilitation Medicine (ÖGPMR) and the Austrian Society of Nephrology (ÖGN)]. Wien Med Wochenschr 2022. [PMID: 36542221 DOI: 10.1007/s10354-022-00989-0] [Reference Citation Analysis]
|
| 5 |
Song Y, Zhang Q, Ni L, Zhang M, Wang M, Zhang W, Chen J. Risk Factors Affecting Muscle Mass Decline in Maintenance Hemodialysis Patients. Biomed Res Int 2022;2022:2925216. [PMID: 36582602 DOI: 10.1155/2022/2925216] [Reference Citation Analysis]
|
| 6 |
Trisiana DY, Yani FF, Amelin F, Pabuti A. Calcitriol levels and the stage of chronic kidney disease in children. PI 2022;62:318-23. [DOI: 10.14238/pi62.5.2022.318-23] [Reference Citation Analysis]
|
| 7 |
Buyukdemirci S, Oguz EG, Cimen SG, Sahin H, Cimen S, Ayli MD. Vitamin D deficiency may predispose patients to increased risk of kidney transplant rejection. World J Transplant 2022; 12(9): 299-309 [DOI: 10.5500/wjt.v12.i9.299] [Reference Citation Analysis]
|
| 8 |
Yazdan Balçik O, Bora F, Köksoy S, Ersoy FF. EVALUATION OF VITAMIN D RECEPTOR LEVEL IN HEMATOPOETIC CELLS AND INFLAMMATORY MARKERS IN STAGE 3-5 CHRONIC RENAL PATIENTS. Akd Tıp D 2022. [DOI: 10.53394/akd.1059539] [Reference Citation Analysis]
|
| 9 |
Ureña Torres PA, Souberbielle JC, Solal MC. Bone Fragility in Chronic Kidney Disease Stage 3 to 5: The Use of Vitamin D Supplementation. Metabolites 2022;12:266. [DOI: 10.3390/metabo12030266] [Reference Citation Analysis]
|
| 10 |
Matuszkiewicz-rowińska J, Kulicki P, Zebrowski P, Klatko W, Sokalski A, Niemczyk S, Wypych-birecka M, Małyszko J. Cholecalciferol vs. Small Doses of Alfacalcidol vs. Placebo in Chronic Kidney Disease Patients on Hemodialysis: A Randomized Parallel Group Study. Front Med 2022;8:781191. [DOI: 10.3389/fmed.2021.781191] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 11 |
Bellorin-font E, Voinescu A, Martin KJ. Calcium, phosphate, PTH, vitamin D, and FGF-23 in CKD-mineral and bone disorder. Nutritional Management of Renal Disease 2022. [DOI: 10.1016/b978-0-12-818540-7.00013-6] [Reference Citation Analysis]
|
| 12 |
Chiang JM, Johansen K. Anabolic and anticatabolic agents in kidney disease and kidney failure. Nutritional Management of Renal Disease 2022. [DOI: 10.1016/b978-0-12-818540-7.00040-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 13 |
Tasnim N, Dutta P, Nayeem J, Masud P, Ferdousi A, Ghosh AS, Hossain M, Rajia S, Kubra KT, Sakibuzzaman M, Khan AT. Osteoporosis, an Inevitable Circumstance of Chronic Kidney Disease: A Systematic Review. Cureus 2021;13:e18488. [PMID: 34692259 DOI: 10.7759/cureus.18488] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 14 |
Yoshida K, Yonaha T, Yamanouchi M, Sumi H, Taki Y, Otobe Y, Miyashita M, Hachisuka R, Han W, Shibagaki Y, Tominaga N. Welfare receipt and the risk of vitamin D deficiency in Japanese patients on maintenance hemodialysis: a cross-sectional, retrospective study. Ren Replace Ther 2021;7:45. [PMID: 34466274 DOI: 10.1186/s41100-021-00364-6] [Reference Citation Analysis]
|
| 15 |
Martínez-Arias L, Panizo S, Alonso-Montes C, Martín-Vírgala J, Martín-Carro B, Fernández-Villabrille S, García Gil-Albert C, Palomo-Antequera C, Fernández-Martín JL, Ruiz-Torres MP, Dusso AS, Carrillo-López N, Cannata-Andía JB, Naves-Díaz M. Effects of calcitriol and paricalcitol on renal fibrosis in CKD. Nephrol Dial Transplant 2021;36:793-803. [PMID: 33416889 DOI: 10.1093/ndt/gfaa373] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 16 |
Bargagli M, Arena M, Naticchia A, Gambaro G, Mazzaferro S, Fuster D, Ferraro PM. The Role of Diet in Bone and Mineral Metabolism and Secondary Hyperparathyroidism. Nutrients 2021;13:2328. [PMID: 34371838 DOI: 10.3390/nu13072328] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 17 |
Tuey SM, Atilano-Roque A, Charkoftaki G, Thurman JM, Nolin TD, Joy MS. Influence of vitamin D treatment on functional expression of drug disposition pathways in human kidney proximal tubule cells during simulated uremia. Xenobiotica 2021;51:657-67. [PMID: 33870862 DOI: 10.1080/00498254.2021.1909783] [Reference Citation Analysis]
|
| 18 |
Mahmoud T, Borgi L. The Interplay Between Nutrition, Metabolic, and Endocrine Disorders in Chronic Kidney Disease. Semin Nephrol 2021;41:180-8. [PMID: 34140096 DOI: 10.1016/j.semnephrol.2021.03.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 19 |
Ziemińska M, Sieklucka B, Pawlak K. Vitamin K and D Supplementation and Bone Health in Chronic Kidney Disease-Apart or Together? Nutrients 2021;13:809. [PMID: 33804453 DOI: 10.3390/nu13030809] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 20 |
Das B, Hait N, Rout JK, Jana D. STUDY THE SERUM VITAMIN D LEVELS IN PATIENTS OF CHRONIC KIDNEY DISEASE. ijsr. [DOI: 10.36106/ijsr/0703036] [Reference Citation Analysis]
|
| 21 |
Tapper M, McGrowder DA, Dilworth L, Soyibo A. Cystatin C, Vitamin D and Thyroid Function Test Profile in Chronic Kidney Disease Patients. Diseases 2021;9:5. [PMID: 33401560 DOI: 10.3390/diseases9010005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 22 |
Panizo S, Martínez-Arias L, Alonso-Montes C, Cannata P, Martín-Carro B, Fernández-Martín JL, Naves-Díaz M, Carrillo-López N, Cannata-Andía JB. Fibrosis in Chronic Kidney Disease: Pathogenesis and Consequences. Int J Mol Sci 2021;22:E408. [PMID: 33401711 DOI: 10.3390/ijms22010408] [Cited by in Crossref: 34] [Cited by in F6Publishing: 38] [Article Influence: 17.0] [Reference Citation Analysis]
|
| 23 |
魏 凡. Correlation between PTH, FT3 and Dominant Proteinuria in Diabetic Kidney Disease. ACM 2021;11:6061-6066. [DOI: 10.12677/acm.2021.1112898] [Reference Citation Analysis]
|
| 24 |
Areepong S, Ouppatham O, Satirapoj B. EFFICACY OF DOUBLE DOSE VERSUS STANDARD DOSE ERGOCALCIFEROL ON VITAMIN D STATUS AMONG PATIENTS WITH CHRONIC KIDNEY DISEASE. J Southeast Asian Med Res 2020;4:59-66. [DOI: 10.55374/jseamed.v4i2.70] [Reference Citation Analysis]
|
| 25 |
Etminan A, Seyed Askari SM, Naghibzade Tahami A, Adel Mahdi S, Behzadi M, Shabani M. Relationship between the serum levels of Vitamin D and inflammatory markers in ESRD patients. Acta Biomed 2020;91:e2020099. [PMID: 33525284 DOI: 10.23750/abm.v91i4.8223] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 26 |
Viswanathan G, Raja PB, Thirumoorthy K, Deepa R, Siva Ilango S. Pathways of factors exacerbating dental fluorosis risk at high altitude regions — A review. Environmental Technology & Innovation 2020;20:101115. [DOI: 10.1016/j.eti.2020.101115] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 27 |
Sah SK, Adhikary LP. Association Between Dyslipidemia and Serum Level of 25-Hydroxyvitamin-D in Early Chronic Kidney Disease, Not on Dialysis: An Observational Cross-Sectional Study from the Himalayan Country. Int J Nephrol Renovasc Dis 2020;13:211-8. [PMID: 33061530 DOI: 10.2147/IJNRD.S267252] [Reference Citation Analysis]
|
| 28 |
Meléndez-Flores JD, Estrada-Bellmann I. Linking chronic kidney disease and Parkinson's disease: a literature review. Metab Brain Dis 2021;36:1-12. [PMID: 32990929 DOI: 10.1007/s11011-020-00623-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 29 |
Malekmakan L, Karimi Z, Mansourian A, Pakfetrat M, Roozbeh J, Rahimi Jaberi K. Role of vitamin D in oxidative stress modulation in end-stage renal disease patients: A double-blind randomized clinical trial. Hemodial Int 2020;24:367-73. [PMID: 32519507 DOI: 10.1111/hdi.12849] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 30 |
Jayaraj JM, Reteti E, Kesavan C, Muthusamy K. Structural insights on vitamin D receptor and screening of new potent agonist molecules: structure and ligand-based approach. Journal of Biomolecular Structure and Dynamics 2021;39:4148-59. [DOI: 10.1080/07391102.2020.1775122] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 31 |
Su Y, Leung J, Lee J, Ho KF, Kwok T. The effect of physical activity on dose-relationship between serum 25-hydroxyvitamin D and cardiovascular health events in older adults. Nutr Metab Cardiovasc Dis 2020;30:656-65. [PMID: 32151483 DOI: 10.1016/j.numecd.2019.12.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 32 |
Yavuz D, Demirağ MD, Yavuz R, Karagöz Özen DS, Ramazanoğlu ZB. 25-Hydroxy vitamin D level is associated with sleep disturbances in patients with chronic kidney disease on hemodialysis: a cross-sectional study. Turk J Med Sci 2020;50:298-303. [PMID: 31887852 DOI: 10.3906/sag-1908-87] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 33 |
Hou YC, Lu CL, Zheng CM, Liu WC, Yen TH, Chen RM, Lin YF, Chao CT, Lu KC. The Role of Vitamin D in Modulating Mesenchymal Stem Cells and Endothelial Progenitor Cells for Vascular Calcification. Int J Mol Sci 2020;21:E2466. [PMID: 32252330 DOI: 10.3390/ijms21072466] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 34 |
Voo VTF, Stankovich J, O'Brien TJ, Butzkueven H, Monif M. Vitamin D status in an Australian patient population: a large retrospective case series focusing on factors associated with variations in serum 25(OH)D. BMJ Open 2020;10:e032567. [PMID: 32139482 DOI: 10.1136/bmjopen-2019-032567] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 35 |
Mehrotra S, Sharma RK, Mayya M. Vitamin D Receptor Activity, Vitamin D Status, and Development of De-novo Donor-specific Antibody after Renal Transplantation. Indian J Nephrol 2020;30:72-6. [PMID: 32269429 DOI: 10.4103/ijn.IJN_353_18] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 36 |
Jones G, Pike JW. Vitamin D and its analogs. Principles of Bone Biology 2020. [DOI: 10.1016/b978-0-12-814841-9.00075-0] [Reference Citation Analysis]
|
| 37 |
Nowak KL, Chonchol M. Management of Mineral and Bone Disorders in Chronic Kidney Disease. Chronic Renal Disease 2020. [DOI: 10.1016/b978-0-12-815876-0.00062-0] [Reference Citation Analysis]
|
| 38 |
Stucchi A, Conte F, Galassi A, Ciceri P, Cozzolino M. Vitamin D receptor activation and prevention of arterial aging. Molecular Nutrition 2020. [DOI: 10.1016/b978-0-12-811907-5.00006-3] [Reference Citation Analysis]
|
| 39 |
Al-suhaimi EA, Al-khater KM, Aljafary MA, Ravinayagam V, Shehzad A, Al-dossary HA, Assuhaimi RA, Tarhini M, Elaissari A. Vitamin D as therapeutic agent acting against cancers caused by proteases. Cancer-Leading Proteases 2020. [DOI: 10.1016/b978-0-12-818168-3.00015-2] [Reference Citation Analysis]
|
| 40 |
Sah SK, Adhikary LP. Prevalence of abnormal serum 25-hydroxyvitamin D and its association with hemoglobin level in pre dialysis CKD patients: a cross-sectional study from Himalayan country. BMC Nephrol 2019;20:267. [DOI: 10.1186/s12882-019-1443-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 41 |
Dix CF, Barcley JL, Wright ORL. The role of vitamin D in adipogenesis. Nutr Rev 2018;76:47-59. [PMID: 29244099 DOI: 10.1093/nutrit/nux056] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 42 |
Alfieri C, Ruzhytska O, Vettoretti S, Caldiroli L, Cozzolino M, Messa P. Native Hypovitaminosis D in CKD Patients: From Experimental Evidence to Clinical Practice. Nutrients 2019;11:E1918. [PMID: 31443249 DOI: 10.3390/nu11081918] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 43 |
Drotningsvik A, Midttun Ø, Vikøren LA, Mccann A, Ueland PM, Mellgren G, Gudbrandsen OA. Urine and plasma concentrations of amino acids and plasma vitamin status differ, and are differently affected by salmon intake, in obese Zucker fa/fa rats with impaired kidney function and in Long-Evans rats with healthy kidneys. Br J Nutr 2019;122:262-73. [DOI: 10.1017/s0007114519001284] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 44 |
Liu M, Wang J, He Y. Serum 25-Hydroxyvitamin D were associated with higher risk of both albuminuria and impaired GFR incidence: a cohort study based on CLHLS study. BMC Nephrol 2019;20:20. [PMID: 30646860 DOI: 10.1186/s12882-019-1202-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 45 |
Denburg M, de Boer I. Vitamin D Disorders in Chronic Kidney Disease. Chronic Kidney Disease, Dialysis, and Transplantation 2019. [DOI: 10.1016/b978-0-323-52978-5.00011-2] [Reference Citation Analysis]
|
| 46 |
Pan HC, Sun CY, Wu IW, Tsai TL, Sun CC, Lee CC. Higher risk of malignant neoplasms in young adults with end-stage renal disease receiving haemodialysis: A nationwide population-based study. Nephrology (Carlton) 2019;24:1165-71. [PMID: 30584693 DOI: 10.1111/nep.13555] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 47 |
Lu CL, Yeih DF, Hou YC, Jow GM, Li ZY, Liu WC, Zheng CM, Lin YF, Shyu JF, Chen R, Huang CY, Lu KC. The Emerging Role of Nutritional Vitamin D in Secondary Hyperparathyroidism in CKD. Nutrients 2018;10:E1890. [PMID: 30513912 DOI: 10.3390/nu10121890] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 48 |
Oh HJ, Lee HA, Moon CM, Ryu DR. Incidence risk of various types of digestive cancers in patients with pre-dialytic chronic kidney disease: A nationwide population-based cohort study. PLoS One 2018;13:e0207756. [PMID: 30458033 DOI: 10.1371/journal.pone.0207756] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 49 |
Timalsina S, Sigdel MR, Baniya S, Subedee S. Status of vitamin D and parameters of calcium homeostasis in renal transplant recipients in Nepal: a cross sectional study. BMC Nephrol 2018;19:290. [PMID: 30348109 DOI: 10.1186/s12882-018-1088-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 50 |
Melamed ML, Chonchol M, Gutiérrez OM, Kalantar-Zadeh K, Kendrick J, Norris K, Scialla JJ, Thadhani R. The Role of Vitamin D in CKD Stages 3 to 4: Report of a Scientific Workshop Sponsored by the National Kidney Foundation. Am J Kidney Dis 2018;72:834-45. [PMID: 30297082 DOI: 10.1053/j.ajkd.2018.06.031] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 6.4] [Reference Citation Analysis]
|
| 51 |
Escoli R, Carvalho MJ, Cabrita A, Rodrigues A. Diastolic Dysfunction, an Underestimated New Challenge in Dialysis. Ther Apher Dial 2019;23:108-17. [PMID: 30255628 DOI: 10.1111/1744-9987.12756] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 52 |
Zaheer S, Taquechel K, Brown JM, Adler GK, Williams JS, Vaidya A. A randomized intervention study to evaluate the effect of calcitriol therapy on the renin-angiotensin system in diabetes. J Renin Angiotensin Aldosterone Syst 2018;19:1470320317754178. [PMID: 29562806 DOI: 10.1177/1470320317754178] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 53 |
Franca Gois PH, Wolley M, Ranganathan D, Seguro AC. Vitamin D Deficiency in Chronic Kidney Disease: Recent Evidence and Controversies. Int J Environ Res Public Health 2018;15:E1773. [PMID: 30126163 DOI: 10.3390/ijerph15081773] [Cited by in Crossref: 49] [Cited by in F6Publishing: 48] [Article Influence: 9.8] [Reference Citation Analysis]
|
| 54 |
Chacar F, Kogika M, Sanches TR, Caragelasco D, Martorelli C, Rodrigues C, Capcha JMC, Chew D, Andrade L. Urinary Tamm-Horsfall protein, albumin, vitamin D-binding protein, and retinol-binding protein as early biomarkers of chronic kidney disease in dogs. Physiol Rep 2017;5:e13262. [PMID: 28576851 DOI: 10.14814/phy2.13262] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 55 |
Lim WH, Duncan EL. Is there a role or target value for nutritional vitamin D in chronic kidney disease? Nephrology (Carlton) 2017;22 Suppl 2:57-64. [PMID: 28429558 DOI: 10.1111/nep.13027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 56 |
Panwar B, Gutiérrez OM. Disorders of Iron Metabolism and Anemia in Chronic Kidney Disease. Semin Nephrol 2016;36:252-61. [PMID: 27475656 DOI: 10.1016/j.semnephrol.2016.05.002] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 7.4] [Reference Citation Analysis]
|
| 57 |
Weidner N, Verbrugghe A. Current knowledge of vitamin D in dogs. Crit Rev Food Sci Nutr 2017;57:3850-9. [PMID: 27171904 DOI: 10.1080/10408398.2016.1171202] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 58 |
Petkovich M, Bishop CW. Extended-Release Calcifediol in Renal Disease. Vitamin D 2018. [DOI: 10.1016/b978-0-12-809963-6.00091-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 59 |
Dix CF, Bauer JD, Wright OR. A Systematic Review: Vitamin D Status and Sleeve Gastrectomy. Obes Surg. 2017;27:215-225. [PMID: 27815862 DOI: 10.1007/s11695-016-2436-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 60 |
Dix CF, Bauer JD, Martin I, Rochester S, Duarte Romero B, Prins JB, Wright ORL. Association of Sun Exposure, Skin Colour and Body Mass Index with Vitamin D Status in Individuals Who Are Morbidly Obese. Nutrients 2017;9:E1094. [PMID: 28976930 DOI: 10.3390/nu9101094] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 61 |
Molina P, Carrero JJ, Bover J, Chauveau P, Mazzaferro S, Torres PU; European Renal Nutrition (ERN) and Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Working Groups of the European Renal Association-European Dialysis Transplant Association (ERA-EDTA). Vitamin D, a modulator of musculoskeletal health in chronic kidney disease. J Cachexia Sarcopenia Muscle 2017;8:686-701. [PMID: 28675610 DOI: 10.1002/jcsm.12218] [Cited by in Crossref: 65] [Cited by in F6Publishing: 65] [Article Influence: 10.8] [Reference Citation Analysis]
|
| 62 |
Zhou S, Glowacki J. Chronic kidney disease and vitamin D metabolism in human bone marrow-derived MSCs. Ann N Y Acad Sci 2017;1402:43-55. [PMID: 28926112 DOI: 10.1111/nyas.13464] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 63 |
Zand L, Kumar R. The Use of Vitamin D Metabolites and Analogues in the Treatment of Chronic Kidney Disease. Endocrinol Metab Clin North Am 2017;46:983-1007. [PMID: 29080646 DOI: 10.1016/j.ecl.2017.07.008] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 64 |
Lips P, Goldsmith D, de Jongh R. Vitamin D and osteoporosis in chronic kidney disease. J Nephrol 2017;30:671-5. [PMID: 28940158 DOI: 10.1007/s40620-017-0430-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 65 |
Sarno G, Nappi R, Altieri B, Tirabassi G, Muscogiuri E, Salvio G, Paschou SA, Ferrara A, Russo E, Vicedomini D, Vincenzo C, Vryonidou A, Della Casa S, Balercia G, Orio F, De Rosa P. Current evidence on vitamin D deficiency and kidney transplant: What's new? Rev Endocr Metab Disord 2017;18:323-34. [PMID: 28281103 DOI: 10.1007/s11154-017-9418-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 66 |
Sarkar S. Vitamin D for Depression with a Seasonal Pattern: an Effective Treatment Strategy. IPMRJ 2017;1. [DOI: 10.15406/ipmrj.2017.01.00021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 67 |
Giannini S, Mazzaferro S, Minisola S, De Nicola L, Rossini M, Cozzolino M. Raising awareness on the therapeutic role of cholecalciferol in CKD: a multidisciplinary-based opinion. Endocrine 2018;59:242-59. [PMID: 28726185 DOI: 10.1007/s12020-017-1369-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 68 |
Jalalzadeh M, Mousavinasab SN, Rostami A. Relationship of circulating levels of 25(OH)D with parathyroid hormone in various stages of chronic kidney disease. J Renal Inj Prev 2017;6:264-268. [DOI: 10.15171/jrip.2017.50] [Reference Citation Analysis]
|
| 69 |
Waziri B, Duarte R, Naicker S. Biochemical markers of mineral bone disorder in South African patients on maintenance haemodialysis. Afr Health Sci 2017;17:445-52. [PMID: 29062340 DOI: 10.4314/ahs.v17i2.19] [Reference Citation Analysis]
|
| 70 |
Małyszko J, Kozlowski L, Kozłowska K, Małyszko M, Małyszko J. Cancer and the kidney: dangereoux liasons or price paid for the progress in medicine? Oncotarget 2017;8:66601-19. [PMID: 29029541 DOI: 10.18632/oncotarget.18094] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 71 |
Friedl C, Zitt E. Vitamin D prohormone in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease. Int J Nephrol Renovasc Dis 2017;10:109-22. [PMID: 28546765 DOI: 10.2147/IJNRD.S97637] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 72 |
Salam SN, Khwaja A, Wilkie ME. Pharmacological Management of Secondary Hyperparathyroidism in Patients with Chronic Kidney Disease. Drugs 2016;76:841-52. [PMID: 27142279 DOI: 10.1007/s40265-016-0575-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 73 |
Zimmerman D, House AA, Kim SJ, Booth RA, Zhang T, Ramsay T, Knoll G. The Risk of Acute Rejection Following Kidney Transplant by 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D Status: A Prospective Cohort Study. Can J Kidney Health Dis 2017;4:2054358117699822. [PMID: 28491335 DOI: 10.1177/2054358117699822] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 74 |
Jhee JH, Kim H, Park S, Yun HR, Jung SY, Kee YK, Yoon CY, Park JT, Han SH, Kang SW, Yoo TH. Vitamin D deficiency is significantly associated with depression in patients with chronic kidney disease. PLoS One 2017;12:e0171009. [PMID: 28192445 DOI: 10.1371/journal.pone.0171009] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 75 |
Hou YC, Liu WC, Zheng CM, Zheng JQ, Yen TH, Lu KC. Role of Vitamin D in Uremic Vascular Calcification. Biomed Res Int 2017;2017:2803579. [PMID: 28286758 DOI: 10.1155/2017/2803579] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 76 |
Jalalzadeh M, Mousavinasab N. Effects of Inactive Vitamin D on Persistent Secondary Hyperparathyroidism in Patients on Hemodialysis. Nephrourol Mon 2017;9. [DOI: 10.5812/numonthly.45029] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 77 |
Patil S, Prajapati P, Gandhi S, Bahulekar A, Pandey Y, Patil O, Afzalpurkar S, Kandagatla S. PREVALENCE OF VITAMIN D DEFICIENCY IN ACUTE CORONARY SYNDROME IN A TERTIARY CARE HOSPITAL, MAHARASHTRA, INDIA. jemds 2017;6:282-285. [DOI: 10.14260/jemds/2017/64] [Reference Citation Analysis]
|
| 78 |
Choksi P, Lawson BR. Secondary Hyperparathyroidism. Medical and Surgical Treatment of Parathyroid Diseases 2017. [DOI: 10.1007/978-3-319-26794-4_7] [Reference Citation Analysis]
|
| 79 |
Meireles MS, Kamimura MA, Dalboni MA, Giffoni de Carvalho JT, Aoike DT, Cuppari L. Effect of cholecalciferol on vitamin D-regulatory proteins in monocytes and on inflammatory markers in dialysis patients: A randomized controlled trial. Clinical Nutrition 2016;35:1251-8. [DOI: 10.1016/j.clnu.2016.04.014] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 80 |
Caravaca-fontán F, Gonzales-candia B, Luna E, Caravaca F. Relative importance of the determinants of serum levels of 25-hydroxy vitamin D in patients with chronic kidney disease. Nefrología (English Edition) 2016;36:510-516. [DOI: 10.1016/j.nefroe.2016.11.010] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 81 |
Kaptein EM, Yi SS, Endres DB, Kaptein JS, Chan LS. Serum 25-hydroxyvitamin D deficiency; a risk factor for chronic kidney disease in ambulatory indigent patients. Endocr Pract 2014;20:236-43. [PMID: 24246347 DOI: 10.4158/EP13303.OR] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 82 |
Caravaca-Fontán F, Gonzales-Candia B, Luna E, Caravaca F. Relative importance of the determinants of serum levels of 25-hydroxy vitamin D in patients with chronic kidney disease. Nefrologia 2016;36:510-6. [PMID: 27378232 DOI: 10.1016/j.nefro.2016.01.017] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 83 |
Vikrant S, Parashar A. Prevalence and severity of disordered mineral metabolism in patients with chronic kidney disease: A study from a tertiary care hospital in India. Indian J Endocrinol Metab 2016;20:460-7. [PMID: 27366711 DOI: 10.4103/2230-8210.183457] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 84 |
Karakas Y, Sahin G, Urfali FE, Bal C, Degirmenci NA, Sirmagul B. Effect of vitamin D supplementation on endothelial dysfunction in hemodialysis patients: Endothelial dysfunction in hemodialysis patients. Hemodialysis International 2017;21:97-106. [DOI: 10.1111/hdi.12439] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 85 |
López-méndez P, Sosa-henríquez M, Ruiz-pérez Á. Relationship between vitamin D deficiency and visually evoked potentials in multiple sclerosis. Archivos de la Sociedad Española de Oftalmología (English Edition) 2016;91:217-222. [DOI: 10.1016/j.oftale.2016.01.017] [Reference Citation Analysis]
|
| 86 |
Lima GAC, Paranhos-neto FDP, Silva LC, de Mendonça LMC, Delgado AG, Leite M, Gomes CP, Farias MLF. Bone Density Is Directly Associated With Glomerular Filtration and Metabolic Acidosis but Do Not Predict Fragility Fractures in Men With Moderate Chronic Kidney Disease. Journal of Clinical Densitometry 2016;19:146-53. [DOI: 10.1016/j.jocd.2014.01.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 87 |
Xiao X, Wang Y, Hou Y, Han F, Ren J, Hu Z. Vitamin D deficiency and related risk factors in patients with diabetic nephropathy. J Int Med Res 2016;44:673-84. [PMID: 26944386 DOI: 10.1177/0300060515593765] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 88 |
López-Méndez P, Sosa-Henríquez M, Ruiz-Pérez Á. Relationship between vitamin D deficiency and visually evoked potentials in multiple sclerosis. Arch Soc Esp Oftalmol 2016;91:217-22. [PMID: 26896059 DOI: 10.1016/j.oftal.2016.01.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 89 |
Kochanek M, Said A, Lerma EV. Mineral metabolism in chronic kidney disease. Dis Mon 2015;61:425-33. [PMID: 26518114 DOI: 10.1016/j.disamonth.2015.08.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 90 |
Metzger M, Stengel B. Epidemiology of Vitamin D Deficiency in Chronic Kidney Disease. Vitamin D in Chronic Kidney Disease 2016. [DOI: 10.1007/978-3-319-32507-1_2] [Reference Citation Analysis]
|
| 91 |
Negri AL, del Valle E, Spivacow FR. Which Vitamin D in Chronic Kidney Disease: Nutritional or Active Vitamin D? Or Both? Vitamin D in Chronic Kidney Disease 2016. [DOI: 10.1007/978-3-319-32507-1_29] [Reference Citation Analysis]
|
| 92 |
Yamada S. Impaired Parathyroid Function and Bone Formation: A Risk for Development of Adynamic Bone Disease to Enhance Vascular Calcification. Musculoskeletal Disease Associated with Diabetes Mellitus 2016. [DOI: 10.1007/978-4-431-55720-3_7] [Reference Citation Analysis]
|
| 93 |
Basile C, Brandenburg V, Ureña Torres PA. Natural Vitamin D in Chronic Kidney Disease. Vitamin D in Chronic Kidney Disease 2016. [DOI: 10.1007/978-3-319-32507-1_28] [Reference Citation Analysis]
|
| 94 |
Miskulin DC, Majchrzak K, Tighiouart H, Muther RS, Kapoian T, Johnson DS, Weiner DE. Ergocalciferol Supplementation in Hemodialysis Patients With Vitamin D Deficiency: A Randomized Clinical Trial. J Am Soc Nephrol 2016;27:1801-10. [PMID: 26677862 DOI: 10.1681/ASN.2015040468] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 95 |
Saber A, Fotuhi F, Rostami Z, Einollahi B, Nemati E. Vitamin D Levels After Kidney Transplantation and the Risk of Cytomegalovirus Infection. Nephrourol Mon 2015;7:e29677. [PMID: 26866004 DOI: 10.5812/numonthly.29677] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 96 |
Jean G, Chazot C. La vitamine D et l’insuffisance rénale chronique : les douze points essentiels. Médecine Nucléaire 2015;39:420-5. [DOI: 10.1016/j.mednuc.2015.05.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 97 |
Chazot C, Jean G, Kopple JD. Can Outcomes be Improved in Dialysis Patients by Optimizing Trace Mineral, Micronutrient, and Antioxidant Status?: The Impact of Vitamins and their Supplementation. Semin Dial 2016;29:39-48. [PMID: 26384581 DOI: 10.1111/sdi.12443] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 98 |
Okoye JU, Arodiwe EB, Ulasi II, Ijoma CK, Onodugo OD. Prevalence of CKD-MBD in pre-dialysis patients using biochemical markers in Enugu, South-East Nigeria. Afr Health Sci 2015;15:941-8. [PMID: 26957985 DOI: 10.4314/ahs.v15i3.31] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
|
| 99 |
Hsu C, Wang H, Hsu Y, Chuang S, Huang Y, Chang Y, Liu J, Hsiung CA, Tsai H. Use of Nonsteroidal Anti-Inflammatory Drugs and Risk of Chronic Kidney Disease in Subjects With Hypertension: Nationwide Longitudinal Cohort Study. Hypertension 2015;66:524-33. [DOI: 10.1161/hypertensionaha.114.05105] [Cited by in Crossref: 43] [Cited by in F6Publishing: 47] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 100 |
Biricik E, Güneş Y. Vitamin D and Anaesthesia. Turk J Anaesthesiol Reanim 2015;43:269-73. [PMID: 27366509 DOI: 10.5152/TJAR.2015.28482] [Reference Citation Analysis]
|
| 101 |
Pi HC, Ren YP, Wang Q, Xu R, Dong J. Serum 25-Hydroxyvitamin D Level Could Predict the Risk for Peritoneal Dialysis-Associated Peritonitis. Perit Dial Int 2015;35:729-35. [PMID: 26224791 DOI: 10.3747/pdi.2014.00177] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 102 |
Chokhandre MK, Mahmoud MI, Hakami T, Jafer M, Inamdar AS. Vitamin D & its analogues in type 2 diabetic nephropathy: a systematic review. J Diabetes Metab Disord 2015;14:58. [PMID: 26180775 DOI: 10.1186/s40200-015-0186-6] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 103 |
Jean G, Souberbielle JC, Lechevallier S, Chazot C. Kinetics of serum 25-hydroxyvitamin D in haemodialysis patients treated with monthly oral cholecalciferol. Clin Kidney J 2015;8:388-92. [PMID: 26251704 DOI: 10.1093/ckj/sfv052] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 104 |
Sarno G, Daniele G, Tirabassi G, Chavez AO, Ojo OO, Orio F, Kahleova H, Balercia G, Grant WB, De Rosa P, Colao A, Muscogiuri G. The impact of vitamin D deficiency on patients undergoing kidney transplantation: focus on cardiovascular, metabolic, and endocrine outcomes. Endocrine 2015;50:568-74. [PMID: 25999028 DOI: 10.1007/s12020-015-0632-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 105 |
Kalousova M, Dusilova-Sulkova S, Zakiyanov O, Kostirova M, Safranek R, Tesar V, Zima T. Vitamin D Binding Protein Is Not Involved in Vitamin D Deficiency in Patients with Chronic Kidney Disease. Biomed Res Int 2015;2015:492365. [PMID: 26064917 DOI: 10.1155/2015/492365] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 106 |
De Metrio M, Milazzo V, Rubino M, Cabiati A, Moltrasio M, Marana I, Campodonico J, Cosentino N, Veglia F, Bonomi A, Camera M, Tremoli E, Marenzi G. Vitamin D plasma levels and in-hospital and 1-year outcomes in acute coronary syndromes: a prospective study. Medicine (Baltimore) 2015;94:e857. [PMID: 25984675 DOI: 10.1097/MD.0000000000000857] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 107 |
Ogawa T, Koeda M, Nitta K. Left Ventricular Diastolic Dysfunction in End-Stage Kidney Disease: Pathogenesis, Diagnosis, and Treatment. Ther Apher Dial 2015;19:427-35. [PMID: 25916171 DOI: 10.1111/1744-9987.12301] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 108 |
Pavlovic D, Katicic D, Gulin T, Josipovic J. Vitamin d in the patients with chronic kidney disease: when, to whom and in which form. Mater Sociomed 2015;27:122-4. [PMID: 26005391 DOI: 10.5455/msm.2015.27.122-124] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 109 |
Obi Y, Hamano T, Isaka Y. Prevalence and prognostic implications of vitamin D deficiency in chronic kidney disease. Dis Markers 2015;2015:868961. [PMID: 25883412 DOI: 10.1155/2015/868961] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 110 |
Bhan I, Dobens D, Tamez H, Deferio JJ, Li YC, Warren HS, Ankers E, Wenger J, Tucker JK, Trottier C, Pathan F, Kalim S, Nigwekar SU, Thadhani R. Nutritional vitamin D supplementation in dialysis: a randomized trial. Clin J Am Soc Nephrol 2015;10:611-9. [PMID: 25770176 DOI: 10.2215/CJN.06910714] [Cited by in Crossref: 58] [Cited by in F6Publishing: 59] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 111 |
Abdel-Gayoum AA. Serum vitamin D and parathyroid hormone profiles in patients with various stages of renal disease. Australas Med J 2015;8:33-40. [PMID: 25810785 DOI: 10.4066/AMJ.2015.2252] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 112 |
Butler AM, Olshan AF, Kshirsagar AV, Edwards JK, Nielsen ME, Wheeler SB, Brookhart MA. Cancer incidence among US Medicare ESRD patients receiving hemodialysis, 1996-2009. Am J Kidney Dis 2015;65:763-72. [PMID: 25662835 DOI: 10.1053/j.ajkd.2014.12.013] [Cited by in Crossref: 117] [Cited by in F6Publishing: 123] [Article Influence: 14.6] [Reference Citation Analysis]
|
| 113 |
Sprague SM, Silva AL, Al-Saghir F, Damle R, Tabash SP, Petkovich M, Messner EJ, White JA, Melnick JZ, Bishop CW. Modified-release calcifediol effectively controls secondary hyperparathyroidism associated with vitamin D insufficiency in chronic kidney disease. Am J Nephrol 2014;40:535-45. [PMID: 25572630 DOI: 10.1159/000369939] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 114 |
Jablonski KL, Chonchol M. Management of Mineral and Bone Disorders in Chronic Kidney Disease Patients. Chronic Renal Disease 2015. [DOI: 10.1016/b978-0-12-411602-3.00053-6] [Reference Citation Analysis]
|
| 115 |
Egshatyan LV, Rozhinskaya LY. MEDICAL METHODS OF CORRECTION OF RENAL OSTEODYSTROPHY. Osteopor Bone Dis 2014;17:29-35. [DOI: 10.14341/osteo2014229-35] [Reference Citation Analysis]
|
| 116 |
Baxmann AC, Menon VB, Medina-Pestana JO, Carvalho AB, Heilberg IP. Overweight and body fat are predictors of hypovitaminosis D in renal transplant patients. Clin Kidney J 2015;8:49-53. [PMID: 25713710 DOI: 10.1093/ckj/sfu120] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 117 |
Polidoro M. CKD-MBD: A “Resistant” Case. Giornale di Tecniche Nefrologiche e Dialitiche 2014;26:348-353. [DOI: 10.5301/gtnd.2014.12817] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 118 |
Dusilová-Sulková S, Šafránek R, Vávrová J, Horáček J, Pavlíková L, Palička V. Low-dose cholecalciferol supplementation and dual vitamin D therapy in haemodialysis patients. Int Urol Nephrol 2015;47:169-76. [PMID: 25262147 DOI: 10.1007/s11255-014-0842-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 119 |
Del Valle E, Negri AL, Fradinger E, Canalis M, Bevione P, Curcelegui M, Bravo M, Puddu M, Marini A, Ryba J, Peri P, Rosa Diez G, Sintado L, Gottlieb E. Weekly high-dose ergocalciferol to correct vitamin D deficiency/insufficiency in hemodialysis patients: a pilot trial. Hemodial Int 2015;19:60-5. [PMID: 25231816 DOI: 10.1111/hdi.12209] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 120 |
Tak YJ, Lee JG, Song SH, Kim YJ, Lee S, Jung DW, Yi YH, Cho YH, Choi EJ, Hwang HR. The relationship between the level of serum 25-hydroxyvitamin D and renal function in patients without chronic kidney disease: a cross-sectional study. J Ren Nutr 2015;25:88-96. [PMID: 25238696 DOI: 10.1053/j.jrn.2014.07.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 121 |
Gonçalves JG, de Bragança AC, Canale D, Shimizu MH, Sanches TR, Moysés RM, Andrade L, Seguro AC, Volpini RA. Vitamin D deficiency aggravates chronic kidney disease progression after ischemic acute kidney injury. PLoS One 2014;9:e107228. [PMID: 25222475 DOI: 10.1371/journal.pone.0107228] [Cited by in Crossref: 50] [Cited by in F6Publishing: 53] [Article Influence: 5.6] [Reference Citation Analysis]
|
| 122 |
Jones G. Interpreting vitamin D assay results: proceed with caution. Clin J Am Soc Nephrol 2015;10:331-4. [PMID: 25107951 DOI: 10.2215/CJN.05490614] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 123 |
Canale D, de Bragança AC, Gonçalves JG, Shimizu MH, Sanches TR, Andrade L, Volpini RA, Seguro AC. Vitamin D deficiency aggravates nephrotoxicity, hypertension and dyslipidemia caused by tenofovir: role of oxidative stress and renin-angiotensin system. PLoS One 2014;9:e103055. [PMID: 25048368 DOI: 10.1371/journal.pone.0103055] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 124 |
Lima GAC, Paranhos Neto FDP, Pereira GRM, Gomes CP, Farias MLF. Osteoporosis management in patient with renal function impairment. Arq Bras Endocrinol Metab 2014;58:530-9. [DOI: 10.1590/0004-2730000003360] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 125 |
Freeman J, Wilson K, Spears R, Shalhoub V, Sibley P. Influence of Vitamin D Binding Protein on Accuracy of 25-Hydroxyvitamin D Measurement Using the ADVIA Centaur Vitamin D Total Assay. Int J Endocrinol 2014;2014:691679. [PMID: 25045351 DOI: 10.1155/2014/691679] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 126 |
Hesketh CC, Knoll GA, Molnar AO, Tsampalieros A, Zimmerman DL. Vitamin D and kidney transplant outcomes: a protocol for a systematic review and meta-analysis. Syst Rev 2014;3:64. [PMID: 24930018 DOI: 10.1186/2046-4053-3-64] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 127 |
Meredith AJ, McManus BM. Vitamin D in heart failure. J Card Fail 2013;19:692-711. [PMID: 24125108 DOI: 10.1016/j.cardfail.2013.09.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 128 |
Liu W, Zhang S, Zhao D, Zou H, Sun N, Liang X, Dard M, Lanske B, Yuan Q. Vitamin D supplementation enhances the fixation of titanium implants in chronic kidney disease mice. PLoS One. 2014;9:e95689. [PMID: 24752599 DOI: 10.1371/journal.pone.0095689] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 129 |
Hanna K, Fassett RG, Gill E, Healy H, Kimlin M, Ross L, Ash S. Serum 25-hydroxy vitamin D concentrations are more deficient/insufficient in peritoneal dialysis than haemodialysis patients in a sunny climate. J Hum Nutr Diet 2015;28:209-18. [PMID: 24720834 DOI: 10.1111/jhn.12234] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 130 |
Molsted S, Eiken P, Andersen JL, Eidemak I, Harrison AP. Interleukin-6 and vitamin D status during high-intensity resistance training in patients with chronic kidney disease. Biomed Res Int 2014;2014:176190. [PMID: 24800209 DOI: 10.1155/2014/176190] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 131 |
Gupta A. Management of osteoporosis in patients with chronic kidney disease. Br J Hosp Med (Lond) 2014;75:83-9. [PMID: 24521803 DOI: 10.12968/hmed.2014.75.2.83] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 132 |
Nigwekar SU, Tamez H, Thadhani RI. Vitamin D and chronic kidney disease-mineral bone disease (CKD-MBD). Bonekey Rep 2014;3:498. [PMID: 24605215 DOI: 10.1038/bonekey.2013.232] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 133 |
Lang CL, Wang MH, Chiang CK, Lu KC. Vitamin D and the Immune System from the Nephrologist's Viewpoint. ISRN Endocrinol 2014;2014:105456. [PMID: 24587915 DOI: 10.1155/2014/105456] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 134 |
Kang EG, Lee JH, Park YS. Chronic Kidney Disease-mineral Bone Disorder and Active Vitamin D Analogs for Treating Severe Hyperparathyroidism in Children Receiving Chronic Peritoneal Dialysis. J Korean Soc Pediatr Nephrol 2014;18:64. [DOI: 10.3339/jkspn.2014.18.2.64] [Reference Citation Analysis]
|
| 135 |
Whitham D, Parpia AS. Diabetes Mellitus and Chronic Kidney Disease (Stages 1–5). Nutrition in Kidney Disease 2014. [DOI: 10.1007/978-1-62703-685-6_8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 136 |
Fernández-Juárez G, Luño J, Barrio V, de Vinuesa SG, Praga M, Goicoechea M, Lahera V, Casas L, Oliva J; PRONEDI Study Group. 25 (OH) vitamin D levels and renal disease progression in patients with type 2 diabetic nephropathy and blockade of the renin-angiotensin system. Clin J Am Soc Nephrol 2013;8:1870-6. [PMID: 24135218 DOI: 10.2215/CJN.00910113] [Cited by in Crossref: 53] [Cited by in F6Publishing: 59] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 137 |
Chaiamnuay S, Chailurkit LO, Narongroeknawin P, Asavatanabodee P, Laohajaroensombat S, Chaiamnuay P. Current daily glucocorticoid use and serum creatinine levels are associated with lower 25(OH) vitamin D levels in Thai patients with systemic lupus erythematosus. J Clin Rheumatol 2013;19:121-5. [PMID: 23519176 DOI: 10.1097/RHU.0b013e318289bd16] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 138 |
Bosworth C, de Boer IH. Impaired vitamin D metabolism in CKD. Semin Nephrol 2013;33:158-68. [PMID: 23465502 DOI: 10.1016/j.semnephrol.2012.12.016] [Cited by in Crossref: 58] [Cited by in F6Publishing: 46] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 139 |
Molina P, Gorriz JL, Molina MD, Peris A, Beltran S, Kanter J, Escudero V, Romero R, Pallardo LM. The effect of cholecalciferol for lowering albuminuria in chronic kidney disease: a prospective controlled study. Nephrology Dialysis Transplantation 2014;29:97-109. [DOI: 10.1093/ndt/gft360] [Cited by in Crossref: 49] [Cited by in F6Publishing: 52] [Article Influence: 4.9] [Reference Citation Analysis]
|
| 140 |
Brown JM, Secinaro K, Williams JS, Vaidya A. Evaluating hormonal mechanisms of vitamin D receptor agonist therapy in diabetic kidney disease: the VALIDATE-D study. BMC Endocr Disord 2013;13:33. [PMID: 23971740 DOI: 10.1186/1472-6823-13-33] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 141 |
Metzger M, Houillier P, Gauci C, Haymann JP, Flamant M, Thervet E, Boffa JJ, Vrtovsnik F, Froissart M, Stengel B, Ureña-Torres P; NephroTest Study Group. Relation between circulating levels of 25(OH) vitamin D and parathyroid hormone in chronic kidney disease: quest for a threshold. J Clin Endocrinol Metab 2013;98:2922-8. [PMID: 23633202 DOI: 10.1210/jc.2013-1294] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 142 |
Mac-way F, Azzouz L, Noel C, Lafage-proust M. Osteomalacia induced by vitamin D deficiency in hemodialysis patients: the crucial role of vitamin D correction. J Bone Miner Metab 2014;32:215-9. [DOI: 10.1007/s00774-013-0480-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 143 |
Fukagawa M, Yokoyama K, Koiwa F, Taniguchi M, Shoji T, Kazama JJ, Komaba H, Ando R, Kakuta T, Fujii H, Nakayama M, Shibagaki Y, Fukumoto S, Fujii N, Hattori M, Ashida A, Iseki K, Shigematsu T, Tsukamoto Y, Tsubakihara Y, Tomo T, Hirakata H, Akizawa T; CKD-MBD Guideline Working Group, Japanese Society for Dialysis Therapy. Clinical Practice Guideline for the Management of Chronic Kidney Disease-Mineral and Bone Disorder: JSDT Clinical Guideline on CKD-MBD. Therapeutic Apheresis and Dialysis 2013;17:247-88. [DOI: 10.1111/1744-9987.12058] [Cited by in Crossref: 239] [Cited by in F6Publishing: 251] [Article Influence: 23.9] [Reference Citation Analysis]
|
| 144 |
Bentli R, Taskapan H, Toktaş H, Ulutas O, Ozkahraman A, Comert M. Significant independent predictors of vitamin d deficiency in inpatients and outpatients of a nephrology unit. Int J Endocrinol 2013;2013:237869. [PMID: 23737771 DOI: 10.1155/2013/237869] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 145 |
Hewitt NA, O'Connor AA, O'Shaughnessy DV, Elder GJ. Effects of cholecalciferol on functional, biochemical, vascular, and quality of life outcomes in hemodialysis patients. Clin J Am Soc Nephrol 2013;8:1143-9. [PMID: 23493381 DOI: 10.2215/CJN.02840312] [Cited by in Crossref: 71] [Cited by in F6Publishing: 74] [Article Influence: 7.1] [Reference Citation Analysis]
|
| 146 |
Delanaye P, Weekers L, Warling X, Moonen M, Smelten N, Médart L, Krzesinski J, Cavalier E. Cholecalciferol in haemodialysis patients: a randomized, double-blind, proof-of-concept and safety study. Nephrology Dialysis Transplantation 2013;28:1779-86. [DOI: 10.1093/ndt/gft001] [Cited by in Crossref: 58] [Cited by in F6Publishing: 60] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 147 |
Pillar R, G Lopes MG, Rocha LA, Cuppari L, Carvalho AB, Draibe SA, Canziani ME. Severe hypovitaminosis D in chronic kidney disease: association with blood pressure and coronary artery calcification. Hypertens Res. 2013;36:428-432. [PMID: 23364344 DOI: 10.1038/hr.2012.230] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 148 |
Braun AB, Litonjua AA, Moromizato T, Gibbons FK, Giovannucci E, Christopher KB. Association of low serum 25-hydroxyvitamin D levels and acute kidney injury in the critically ill. Crit Care Med. 2012;40:3170-3179. [PMID: 22975885 DOI: 10.1097/ccm.0b013e318260c928] [Cited by in Crossref: 81] [Cited by in F6Publishing: 89] [Article Influence: 8.1] [Reference Citation Analysis]
|
| 149 |
Whiting SJ, Calvo MS. Current Understanding of Vitamin D Metabolism, Nutritional Status, and Role in Disease Prevention. Nutrition in the Prevention and Treatment of Disease 2013. [DOI: 10.1016/b978-0-12-391884-0.00043-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 150 |
Darryl Quarles L. Management of Calcium and Bone Disease in Renal Patients. Seldin and Giebisch's The Kidney 2013. [DOI: 10.1016/b978-0-12-381462-3.00091-4] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 151 |
Cho HY, Hyun HS, Kang HG, Ha IS, Cheong HI. Prevalence of 25(OH) vitamin D insufficiency and deficiency in pediatric patients on chronic dialysis. Perit Dial Int 2013;33:398-404. [PMID: 23209039 DOI: 10.3747/pdi.2011.00246] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 152 |
Jones G. Vitamin D Analogs and Their Clinical Uses. Oxidative Stress and Disease 2012. [DOI: 10.1201/b13714-5] [Reference Citation Analysis]
|
| 153 |
Reis J, Lutsey P. Vitamin D and Cardiovascular Disease. Oxidative Stress and Disease 2012. [DOI: 10.1201/b13714-20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 154 |
Viaene L, Evenepoel P, Meijers B, Vanderschueren D, Overbergh L, Mathieu C. Uremia suppresses immune signal-induced CYP27B1 expression in human monocytes. Am J Nephrol 2012;36:497-508. [PMID: 23171504 DOI: 10.1159/000345146] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 155 |
Kari JA, El Desoky SM, El-Morshedy SM, Habib HS. Vitamin D insufficiency and deficiency in children with chronic kidney disease. Ann Saudi Med 2012;32:473-8. [PMID: 22871615 DOI: 10.5144/0256-4947.2012.473] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 156 |
Kumar J, Furth SL, Warady BA. Pediatric Patients with Chronic Kidney Disease-Mineral Bone Disorder. Clinic Rev Bone Miner Metab 2012;10:219-234. [DOI: 10.1007/s12018-011-9112-8] [Reference Citation Analysis]
|
| 157 |
Peeters MJ, van Zuilen AD, van den Brand JA, Blankestijn PJ, ten Dam MA, Wetzels JF. Differences between hospitals in attainment of parathyroid hormone treatment targets in chronic kidney disease do not reflect differences in quality of care. BMC Nephrol 2012;13:82. [PMID: 22867424 DOI: 10.1186/1471-2369-13-82] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 158 |
Chau YY, Kumar J. Vitamin D in chronic kidney disease. Indian J Pediatr 2012;79:1062-8. [PMID: 22544696 DOI: 10.1007/s12098-012-0765-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 159 |
Shebl FM, Warren JL, Eggers PW, Engels EA. Cancer risk among elderly persons with end-stage renal disease: a population-based case-control study. BMC Nephrol 2012;13:65. [PMID: 22834953 DOI: 10.1186/1471-2369-13-65] [Cited by in Crossref: 44] [Cited by in F6Publishing: 48] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 160 |
Marckmann P, Agerskov H, Thineshkumar S, Bladbjerg EM, Sidelmann JJ, Jespersen J, Nybo M, Rasmussen LM, Hansen D, Scholze A. Randomized controlled trial of cholecalciferol supplementation in chronic kidney disease patients with hypovitaminosis D. Nephrol Dial Transplant. 2012;27:3523-3531. [PMID: 22822092 DOI: 10.1093/ndt/gfs138] [Cited by in Crossref: 96] [Cited by in F6Publishing: 105] [Article Influence: 8.7] [Reference Citation Analysis]
|
| 161 |
Vaidya A, Forman JP. Vitamin D and vascular disease: the current and future status of vitamin D therapy in hypertension and kidney disease. Curr Hypertens Rep 2012;14:111-9. [PMID: 22328068 DOI: 10.1007/s11906-012-0248-9] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 162 |
Nigwekar SU, Bhan I, Thadhani R. Ergocalciferol and Cholecalciferol in CKD. American Journal of Kidney Diseases 2012;60:139-56. [DOI: 10.1053/j.ajkd.2011.12.035] [Cited by in Crossref: 79] [Cited by in F6Publishing: 82] [Article Influence: 7.2] [Reference Citation Analysis]
|
| 163 |
Qazi RA, Martin KJ. Vitamin D in kidney disease: pathophysiology and the utility of treatment. Rheum Dis Clin North Am 2012;38:115-23. [PMID: 22525847 DOI: 10.1016/j.rdc.2012.03.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 164 |
Sanchez I, Mangoo-karim R, Stubbs JR, Yanev GP, Wetmore JB. Ethnic differences in 25-hydroxyvitamin D levels and response to treatment in CKD. Int Urol Nephrol 2013;45:181-9. [DOI: 10.1007/s11255-012-0200-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 165 |
Holden RM, Ki V, Morton AR, Clase C. Fat-Soluble Vitamins in Advanced CKD/ESKD: A Review: FAT-SOLUBLE VITAMINS IN ESKD. Seminars in Dialysis 2012;25:334-43. [DOI: 10.1111/j.1525-139x.2012.01084.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 166 |
Ennis J, Worcester E, Coe F. Contribution of calcium, phosphorus and 25-hydroxyvitamin D to the excessive severity of secondary hyperparathyroidism in African-Americans with CKD. Nephrology Dialysis Transplantation 2012;27:2847-53. [DOI: 10.1093/ndt/gfs080] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 167 |
García IM, Altamirano L, Mazzei L, Fornés M, Molina MN, Ferder L, Manucha W. Role of mitochondria in paricalcitol-mediated cytoprotection during obstructive nephropathy. Am J Physiol Renal Physiol 2012;302:F1595-605. [PMID: 22492946 DOI: 10.1152/ajprenal.00617.2011] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 168 |
Bhan I, Powe CE, Berg AH, Ankers E, Wenger JB, Karumanchi SA, Thadhani RI. Bioavailable vitamin D is more tightly linked to mineral metabolism than total vitamin D in incident hemodialysis patients. Kidney Int 2012;82:84-9. [PMID: 22398410 DOI: 10.1038/ki.2012.19] [Cited by in Crossref: 154] [Cited by in F6Publishing: 162] [Article Influence: 14.0] [Reference Citation Analysis]
|
| 169 |
Bucharles S, Barberato SH, Stinghen AE, Gruber B, Piekala L, Dambiski AC, Custodio MR, Pecoits-filho R. Impact of Cholecalciferol Treatment on Biomarkers of Inflammation and Myocardial Structure in Hemodialysis Patients Without Hyperparathyroidism. Journal of Renal Nutrition 2012;22:284-91. [DOI: 10.1053/j.jrn.2011.07.001] [Cited by in Crossref: 55] [Cited by in F6Publishing: 57] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 170 |
Jones G. Vitamin D Analogs. Rheumatic Disease Clinics of North America 2012;38:207-32. [DOI: 10.1016/j.rdc.2012.03.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 171 |
Pecoits-filho R, Bucharles S, Barberato SH. Diastolic Heart Failure in Dialysis Patients: Mechanisms, Diagnostic Approach, and Treatment: CARDIOMYOPATHY IN DIALYSIS PATIENTS. Seminars in Dialysis 2012;25:35-41. [DOI: 10.1111/j.1525-139x.2011.01011.x] [Cited by in Crossref: 60] [Cited by in F6Publishing: 69] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 172 |
Oh YJ, Kim M, Lee H, Lee JP, Kim H, Kim S, Oh K, Joo KW, Lim CS, Kim S, Kim YS, Kim DK. A threshold value of estimated glomerular filtration rate that predicts changes in serum 25-hydroxyvitamin D levels: 4th Korean National Health and Nutritional Examination Survey 2008. Nephrology Dialysis Transplantation 2012;27:2396-403. [DOI: 10.1093/ndt/gfr763] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 173 |
Gordon PL, Doyle JW, Johansen KL. Association of 1,25-dihydroxyvitamin D levels with physical performance and thigh muscle cross-sectional area in chronic kidney disease stage 3 and 4. J Ren Nutr 2012;22:423-33. [PMID: 22227183 DOI: 10.1053/j.jrn.2011.10.006] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 174 |
Quarles LD. Vitamin D, Calcimimetic Agents, and Phosphate Binders. Brenner and Rector's The Kidney 2012. [DOI: 10.1016/b978-1-4160-6193-9.10062-4] [Reference Citation Analysis]
|
| 175 |
Brossard J, D’amour P. Primary and Secondary Hyperparathyroidism Testing and Assays. Handbook of Parathyroid Diseases 2012. [DOI: 10.1007/978-1-4614-2164-1_3] [Reference Citation Analysis]
|
| 176 |
Wahl P, Wolf M. FGF23 in Chronic Kidney Disease. Advances in Experimental Medicine and Biology 2012. [DOI: 10.1007/978-1-4614-0887-1_8] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 177 |
Busaidy NL, Lahoti A, Hanley DA. Secondary Hyperparathyroidism. Handbook of Parathyroid Diseases 2012. [DOI: 10.1007/978-1-4614-2164-1_9] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 178 |
Kalkwarf HJ, Denburg MR, Strife CF, Zemel BS, Foerster DL, Wetzsteon RJ, Leonard MB. Vitamin D deficiency is common in children and adolescents with chronic kidney disease. Kidney Int 2012;81:690-7. [PMID: 22205356 DOI: 10.1038/ki.2011.431] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 179 |
Venkatram S, Chilimuri S, Adrish M, Salako A, Patel M, Diaz-Fuentes G. Vitamin D deficiency is associated with mortality in the medical intensive care unit. Crit Care 2011;15:R292. [PMID: 22152332 DOI: 10.1186/cc10585] [Cited by in Crossref: 122] [Cited by in F6Publishing: 137] [Article Influence: 10.2] [Reference Citation Analysis]
|
| 180 |
Vaidya A, Williams JS. The relationship between vitamin D and the renin-angiotensin system in the pathophysiology of hypertension, kidney disease, and diabetes. Metabolism 2012;61:450-8. [PMID: 22075270 DOI: 10.1016/j.metabol.2011.09.007] [Cited by in Crossref: 94] [Cited by in F6Publishing: 102] [Article Influence: 7.8] [Reference Citation Analysis]
|
| 181 |
Barreto FC, de Oliveira RA, Oliveira RB, Jorgetti V. Pharmacotherapy of chronic kidney disease and mineral bone disorder. Expert Opin Pharmacother 2011;12:2627-40. [PMID: 22017388 DOI: 10.1517/14656566.2011.626768] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 182 |
Heaf JG, Joffe P, Marckmann P. Vitamin d and stage 5 chronic kidney disease: a new paradigm? Semin Dial. 2012;25:50-58. [PMID: 21967444 DOI: 10.1111/j.1525-139x.2011.00986.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 183 |
Pipili C, Dimitriadis C, Sekercioglu N, Bargman JM, Oreopoulos DD. Effect of nutritional vitamin D preparations on parathyroid hormone in patients with chronic kidney disease. Int Urol Nephrol 2012;44:167-71. [PMID: 21870088 DOI: 10.1007/s11255-011-0048-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 184 |
Ureña-Torres P, Metzger M, Haymann JP, Karras A, Boffa JJ, Flamant M, Vrtovsnik F, Gauci C, Froissart M, Houillier P, Stengel B; NephroTest Study Group. Association of kidney function, vitamin D deficiency, and circulating markers of mineral and bone disorders in CKD. Am J Kidney Dis 2011;58:544-53. [PMID: 21803465 DOI: 10.1053/j.ajkd.2011.04.029] [Cited by in Crossref: 78] [Cited by in F6Publishing: 82] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 185 |
Vondracek SF, Hoody DW. Combination vitamin D therapy in stage 5 chronic kidney disease. Ann Pharmacother 2011;45:1011-5. [PMID: 21750312 DOI: 10.1345/aph.1P782] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 186 |
D'Amour P, Rousseau L, Hornyak S, Yang Z, Cantor T. Influence of Secondary Hyperparathyroidism Induced by Low Dietary Calcium, Vitamin D Deficiency, and Renal Failure on Circulating Rat PTH Molecular Forms. Int J Endocrinol 2011;2011:469783. [PMID: 21747853 DOI: 10.1155/2011/469783] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 187 |
Santoro D, Gitto L, Ferraro A, Satta E, Savica V, Bellinghieri G. Vitamin D status and mortality risk in patients with chronic kidney disease. Ren Fail 2011;33:184-91. [PMID: 21332341 DOI: 10.3109/0886022X.2011.553303] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 188 |
Figuiredo-Dias V, Cuppari L, Garcia-Lopes MG, de Carvalho AB, Draibe SA, Kamimura MA. Risk factors for hypovitaminosis D in nondialyzed chronic kidney disease patients. J Ren Nutr. 2012;22:4-11. [PMID: 21652219 DOI: 10.1053/j.jrn.2011.02.001] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 189 |
Chonchol M, Kendrick J, Targher G. Extra-skeletal effects of vitamin D deficiency in chronic kidney disease. Ann Med 2011;43:273-82. [PMID: 21214426 DOI: 10.3109/07853890.2010.543923] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 190 |
Gueiros JEB, Hernandes FR, Karohl C, Jorgetti V. Prevenção e tratamento do hiperparatireoidismo secundário na DRC. J Bras Nefrol 2011;33:189-247. [DOI: 10.1590/s0101-28002011000200013] [Reference Citation Analysis]
|
| 191 |
Jakopin E, Balon BP, Ekart R, Gorenjak M. High-Dose Cholecalciferol Supplementation for Vitamin D Deficiency in Haemodialysis Patients. J Int Med Res 2011;39:1099-106. [DOI: 10.1177/147323001103900345] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 192 |
Waller S. Parathyroid hormone and growth in chronic kidney disease. Pediatr Nephrol 2011;26:195-204. [PMID: 20694820 DOI: 10.1007/s00467-010-1614-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 193 |
Moe SM, Sprague SM. Chronic Kidney Disease-Mineral Bone Disorder. Brenner and Rector's The Kidney 2011. [DOI: 10.1016/b978-1-4160-6193-9.10054-5] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 194 |
Cuppari L, Garcia Lopes MG, Kamimura MA. Vitamin D Biology: From the Discovery to Its Significance in Chronic Kidney Disease. Journal of Renal Nutrition 2011;21:113-6. [DOI: 10.1053/j.jrn.2010.10.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 195 |
Thiem U, Borchhardt K. Vitamin D in solid organ transplantation with special emphasis on kidney transplantation. Vitam Horm 2011;86:429-68. [PMID: 21419283 DOI: 10.1016/B978-0-12-386960-9.00019-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 196 |
Bhan I, Hewison M, Thadhani R. Dietary vitamin D intake in advanced CKD/ESRD. Semin Dial 2010;23:407-10. [PMID: 20701720 DOI: 10.1111/j.1525-139X.2010.00751.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 197 |
Hari P, Gupta N, Hari S, Gulati A, Mahajan P, Bagga A. Vitamin D insufficiency and effect of cholecalciferol in children with chronic kidney disease. Pediatr Nephrol 2010;25:2483-8. [PMID: 20872152 DOI: 10.1007/s00467-010-1639-2] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 198 |
Anderson RL, Ternes SB, Strand KA, Rowling MJ. Vitamin D homeostasis is compromised due to increased urinary excretion of the 25-hydroxycholecalciferol-vitamin D-binding protein complex in the Zucker diabetic fatty rat. Am J Physiol Endocrinol Metab 2010;299:E959-67. [PMID: 20876762 DOI: 10.1152/ajpendo.00218.2010] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 199 |
García-Canton C, Bosch E, Ramírez A, Gonzalez Y, Auyanet I, Guerra R, Perez MA, Fernández E, Toledo A, Lago M. Vascular calcification and 25-hydroxyvitamin D levels in non-dialysis patients with chronic kidney disease stages 4 and 5. Nephrol Dial Transplant. 2011;26:2250-2256. [PMID: 20956810 DOI: 10.1093/ndt/gfq650] [Cited by in Crossref: 59] [Cited by in F6Publishing: 64] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 200 |
Stefíková K, Spustová V, Krivošíková Z, Okša A, Gazdíková K, Fedelešová V, Dzúrik R. Insulin resistance and vitamin D deficiency in patients with chronic kidney disease stage 2-3. Physiol Res 2011;60:149-55. [PMID: 20945958 DOI: 10.33549/physiolres.931814] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 201 |
Peñalba A, Alles A, Aralde A, Carreras R, Del-valle E, Forrester M, Mengarelli C, Negri A, Rosa-diez G, Tirado S, Urtiaga L, Slatopolsky E, Cannata-andia JB, Lorenzo-sellares V. Consenso metabolismo óseo y mineral. Sociedad Argentina de Nefrología. Versión 2010. Capítulo III. 25 hidroxi-vitamina D y tratamiento del hiperparatiroidismo secundario en la enfermedad renal crónica estadio 3-5. Diálisis y Trasplante 2010;31:144-147. [DOI: 10.1016/j.dialis.2010.07.007] [Reference Citation Analysis]
|
| 202 |
Jones G. Vitamin D analogs. Endocrinol Metab Clin North Am 2010;39:447-72, table of contents. [PMID: 20511062 DOI: 10.1016/j.ecl.2010.02.003] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 203 |
Baeke F, Gysemans C, Korf H, Mathieu C. Vitamin D insufficiency: implications for the immune system. Pediatr Nephrol 2010;25:1597-606. [PMID: 20180136 DOI: 10.1007/s00467-010-1452-y] [Cited by in Crossref: 72] [Cited by in F6Publishing: 74] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 204 |
Shroff R, Knott C, Rees L. The virtues of vitamin D--but how much is too much? Pediatr Nephrol 2010;25:1607-20. [PMID: 20393752 DOI: 10.1007/s00467-010-1499-9] [Cited by in Crossref: 55] [Cited by in F6Publishing: 54] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 205 |
Gal-moscovici A, Sprague SM. Use of vitamin D in chronic kidney disease patients. Kidney International 2010;78:146-51. [DOI: 10.1038/ki.2010.113] [Cited by in Crossref: 50] [Cited by in F6Publishing: 53] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 206 |
Bandini S. Intervista a Sandro Bandini. Giornale di Tecniche Nefrologiche e Dialitiche 2010;22:31-37. [DOI: 10.1177/039493621002200310] [Reference Citation Analysis]
|
| 207 |
Michaud J, Naud J, Ouimet D, Demers C, Petit JL, Leblond FA, Bonnardeaux A, Gascon-Barré M, Pichette V. Reduced hepatic synthesis of calcidiol in uremia. J Am Soc Nephrol 2010;21:1488-97. [PMID: 20595682 DOI: 10.1681/ASN.2009080815] [Cited by in Crossref: 70] [Cited by in F6Publishing: 74] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 208 |
Peñalba A, Alles A, Aralde A, Carreras R, Del-valle E, Forrester M, Mengarelli C, Negri A, Rosa-diez G, Tirado S, Urtiaga L, Slatopolsky E, Cannata-andia JB, Lorenzo-sellares V. Consenso metabolismo óseo y mineral. Sociedad Argentina de Nefrología. Versión 2010. Introducción y capítulo I. Metabolismo óseo y mineral en la enfermedad renal crónica estadio 3–5. Diálisis y Trasplante 2010;31:101-105. [DOI: 10.1016/j.dialis.2010.07.002] [Reference Citation Analysis]
|
| 209 |
Qazi RA, Martin KJ. Vitamin D in Kidney Disease: Pathophysiology and the Utility of Treatment. Endocrinology and Metabolism Clinics of North America 2010;39:355-63. [DOI: 10.1016/j.ecl.2010.02.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 210 |
Jones G. Why dialysis patients need combination therapy with both cholecalciferol and a calcitriol analogs. Semin Dial 2010;23:239-43. [PMID: 20492584 DOI: 10.1111/j.1525-139X.2010.00722.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 211 |
Cannata-Andía JB, Rodriguez-García M, Román-García P, Tuñón-le Poultel D, López-Hernández F, Rodríguez-Puyol D. New therapies: calcimimetics, phosphate binders and vitamin D receptor activators. Pediatr Nephrol 2010;25:609-16. [PMID: 20151157 DOI: 10.1007/s00467-010-1462-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 212 |
Matias PJ, Jorge C, Ferreira C, Borges M, Aires I, Amaral T, Gil C, Cortez J, Ferreira A. Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters. Clin J Am Soc Nephrol 2010;5:905-11. [PMID: 20203163 DOI: 10.2215/CJN.06510909] [Cited by in Crossref: 157] [Cited by in F6Publishing: 171] [Article Influence: 12.1] [Reference Citation Analysis]
|
| 213 |
Holden RM, Morton AR, Garland JS, Pavlov A, Day AG, Booth SL. Vitamins K and D status in stages 3-5 chronic kidney disease. Clin J Am Soc Nephrol. 2010;5:590-597. [PMID: 20167683 DOI: 10.2215/cjn.06420909] [Cited by in Crossref: 136] [Cited by in F6Publishing: 142] [Article Influence: 10.5] [Reference Citation Analysis]
|
| 214 |
Pelletier S, Chapurlat R. Optimizing bone health in chronic kidney disease. Maturitas 2010;65:325-33. [PMID: 20092971 DOI: 10.1016/j.maturitas.2009.12.021] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 215 |
Moe SM, Saifullah A, LaClair RE, Usman SA, Yu Z. A randomized trial of cholecalciferol versus doxercalciferol for lowering parathyroid hormone in chronic kidney disease. Clin J Am Soc Nephrol 2010;5:299-306. [PMID: 20056760 DOI: 10.2215/CJN.07131009] [Cited by in Crossref: 58] [Cited by in F6Publishing: 61] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 216 |
de Boer IH. Vitamin D Deficiency. Chronic Kidney Disease, Dialysis, and Transplantation 2010. [DOI: 10.1016/b978-1-4377-0987-2.00009-1] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 217 |
Martin KJ, Floege J, Ketteler M. Bone and Mineral Metabolism in Chronic Kidney Disease. Comprehensive Clinical Nephrology 2010. [DOI: 10.1016/b978-0-323-05876-6.00081-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 218 |
Bhan I, Tamez H, Thadhani R. Role of Vitamin D and Vitamin D Analogs for Bone Health and Survival in Chronic Kidney Disease. Vitamin D 2010. [DOI: 10.1007/978-1-60327-303-9_52] [Reference Citation Analysis]
|
| 219 |
Li X, Speer MY, Yang H, Bergen J, Giachelli CM. Vitamin D receptor activators induce an anticalcific paracrine program in macrophages: requirement of osteopontin. Arterioscler Thromb Vasc Biol 2010;30:321-6. [PMID: 19948844 DOI: 10.1161/ATVBAHA.109.196576] [Cited by in Crossref: 27] [Cited by in F6Publishing: 32] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 220 |
Maheut H, Chevriot F, Marty H, Lavaud S, Kazes I, Chanard J, Rieu P. Pourquoi et comment corriger le déficit en calcidiol chez les patients hémodialysés ? Néphrologie & Thérapeutique 2009;5:542-9. [DOI: 10.1016/j.nephro.2009.05.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 221 |
Pittas AG, Laskowski U, Kos L, Saltzman E. Role of vitamin D in adults requiring nutrition support. JPEN J Parenter Enteral Nutr 2010;34:70-8. [PMID: 19875748 DOI: 10.1177/0148607109349061] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 222 |
Doorenbos CRC, van den Born J, Navis G, de Borst MH. Possible renoprotection by vitamin D in chronic renal disease: beyond mineral metabolism. Nat Rev Nephrol 2009;5:691-700. [DOI: 10.1038/nrneph.2009.185] [Cited by in Crossref: 75] [Cited by in F6Publishing: 78] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 223 |
Pečovnik-balon B, Jakopin E, Bevc S, Knehtl M, Gorenjak M. Vitamin D as a Novel Nontraditional Risk Factor for Mortality in Hemodialysis Patients. Therapeutic Apheresis and Dialysis 2009;13:268-72. [DOI: 10.1111/j.1744-9987.2009.00722.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 224 |
References. Kidney International 2009;76:S121-S130. [DOI: 10.1038/ki.2009.197] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 225 |
. Chapter 3.1: Diagnosis of CKD–MBD: biochemical abnormalities. Kidney International 2009;76:S22-49. [DOI: 10.1038/ki.2009.191] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 226 |
Barnato S, Sprague SM. Advances in renal bone disease: Osteoporosis and chronic kidney disease. Curr Rheumatol Rep 2009;11:185-90. [DOI: 10.1007/s11926-009-0025-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 227 |
Isakova T, Gutiérrez OM, Wolf M. A blueprint for randomized trials targeting phosphorus metabolism in chronic kidney disease. Kidney Int 2009;76:705-16. [PMID: 19606082 DOI: 10.1038/ki.2009.246] [Cited by in Crossref: 78] [Cited by in F6Publishing: 79] [Article Influence: 5.6] [Reference Citation Analysis]
|
| 228 |
Sato T, Fukagawa M, Uchida K, Katayama A, Nagasaka T, Matsuoka S, Goto N, Tominaga Y, Kobayashi T, Nakao A. 1,25-dihydroxyvitamin D synthesis after renal transplantation: the role of fibroblast growth factor 23 and cyclosporine. Clinical Transplantation 2009;23:368-74. [DOI: 10.1111/j.1399-0012.2009.00995.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 229 |
Cozzolino M, Gallieni M, Pasho S, Fallabrino G, Ciceri P, Volpi EM, Olivi L, Brancaccio D. Management of Secondary Hyperparathyroidism in the Elderly Patient with Chronic Kidney Disease: . Drugs & Aging 2009;26:457-68. [DOI: 10.2165/00002512-200926060-00002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 230 |
Seeherunvong W, Abitbol CL, Chandar J, Zilleruelo G, Freundlich M. Vitamin D insufficiency and deficiency in children with early chronic kidney disease. J Pediatr 2009;154:906-11.e1. [PMID: 19230902 DOI: 10.1016/j.jpeds.2008.12.006] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 231 |
Zidehsarai MP, Moe SM. Review article: Chronic kidney disease-mineral bone disorder: Have we got the assays right? Nephrology 2009;14:374-82. [DOI: 10.1111/j.1440-1797.2009.01131.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 232 |
Perez-jara J, Enguix A, Fernandez-quintas JM, Gómez-salvador B, Baz R, Olmos P, Rodríguez A, Vilches A, Reyes-ortiz C. Fear of Falling among Elderly Patients with Dizziness and Syncope in a Tilt Setting. Can J Aging 2009;28:157-63. [DOI: 10.1017/s0714980809090151] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 233 |
Thiem U, Heinze G, Segel R, Perkmann T, Kainberger F, Mühlbacher F, Hörl W, Borchhardt K. VITA-D: cholecalciferol substitution in vitamin D deficient kidney transplant recipients: a randomized, placebo-controlled study to evaluate the post-transplant outcome. Trials 2009;10:36. [PMID: 19480654 DOI: 10.1186/1745-6215-10-36] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 234 |
Agarwal R. Vitamin D, proteinuria, diabetic nephropathy, and progression of CKD. Clin J Am Soc Nephrol 2009;4:1523-8. [PMID: 19478099 DOI: 10.2215/CJN.02010309] [Cited by in Crossref: 66] [Cited by in F6Publishing: 72] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 235 |
Martin KJ. When is Vitamin D Contraindicated in Dialysis Patients? Seminars in Dialysis 2009;22:247-9. [DOI: 10.1111/j.1525-139x.2009.00566.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 236 |
Wong G, Hayen A, Chapman JR, Webster AC, Wang JJ, Mitchell P, Craig JC. Association of CKD and cancer risk in older people. J Am Soc Nephrol. 2009;20:1341-1350. [PMID: 19406977 DOI: 10.1681/asn.2008090998] [Cited by in Crossref: 187] [Cited by in F6Publishing: 199] [Article Influence: 13.4] [Reference Citation Analysis]
|
| 237 |
Sahin G, Kirli I, Sirmagul B, Colak E, Yalcin AU. Loss via peritoneal fluid as a factor for low 25(OH)D3 level in peritoneal dialysis patients. Int Urol Nephrol 2009;41:989-96. [DOI: 10.1007/s11255-009-9561-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 238 |
Eddington H, Heaf JG. Clinical management of disturbances of calcium and phosphate metabolism in dialysis patients. NDT Plus 2009;2:267-72. [PMID: 25984012 DOI: 10.1093/ndtplus/sfp044] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 239 |
Tomida K, Hamano T, Mikami S, Fujii N, Okada N, Matsui I, Nagasawa Y, Moriyama T, Ito T, Imai E, Isaka Y, Rakugi H. Serum 25-hydroxyvitamin D as an independent determinant of 1-84 PTH and bone mineral density in non-diabetic predialysis CKD patients. Bone 2009;44:678-83. [DOI: 10.1016/j.bone.2008.11.016] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 240 |
Jabbar Z, Aggarwal PK, Chandel N, Kohli HS, Gupta KL, Sakhuja V, Jha V. High prevalence of vitamin D deficiency in north Indian adults is exacerbated in those with chronic kidney disease. Nephrology 2009;14:345-9. [DOI: 10.1111/j.1440-1797.2008.01082.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 23] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 241 |
Parker BD, Ix JH, Cranenburg EC, Vermeer C, Whooley MA, Schurgers LJ. Association of kidney function and uncarboxylated matrix Gla protein: data from the Heart and Soul Study. Nephrol Dial Transplant. 2009;24:2095-2101. [PMID: 19204017 DOI: 10.1093/ndt/gfp024] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 242 |
Khan SS, Iraniha MR. Diagnosis of renal osteodystrophy among chronic kidney disease patients. Dial Transplant 2009;38:45-57. [DOI: 10.1002/dat.20302] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 243 |
Kooienga L, Fried L, Scragg R, Kendrick J, Smits G, Chonchol M. The effect of combined calcium and vitamin D3 supplementation on serum intact parathyroid hormone in moderate CKD. Am J Kidney Dis. 2009;53:408-416. [PMID: 19185400 DOI: 10.1053/j.ajkd.2008.09.020] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 244 |
Malluche HH, Mawad H, Monier-Faugere MC. Effects of treatment of renal osteodystrophy on bone histology. Clin J Am Soc Nephrol 2008;3 Suppl 3:S157-63. [PMID: 18988701 DOI: 10.2215/CJN.02500607] [Cited by in Crossref: 33] [Cited by in F6Publishing: 37] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 245 |
Cozzolino M, Olivi L, Pasho S, Fallabrino G, Volpi E, Ciceri P. La gestione dell'iperparatiroidismo secondario nella malattia renale cronica allo stadio 3 e 4. Giornale di Tecniche Nefrologiche e Dialitiche 2009;21:37-42. [DOI: 10.1177/039493620902100107] [Reference Citation Analysis]
|
| 246 |
Cuppari L, Garcia-lopes MG. Hypovitaminosis D in Chronic Kidney Disease Patients: Prevalence and Treatment. Journal of Renal Nutrition 2009;19:38-43. [DOI: 10.1053/j.jrn.2008.10.005] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 247 |
Vandevoorde RG, Warady BA. Management of Chronic Kidney Disease. Pediatric Nephrology 2009. [DOI: 10.1007/978-3-540-76341-3_68] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 248 |
Bouchard J, Ouimet D, Vallée M, Lafrance JP, Leblanc M, Sénécal L, Bonnardeaux A, Mathieu JP, Pichette V. Comparison of the prevalence of calcidiol insufficiency in predialysis and osteoporotic populations. Int Urol Nephrol 2009;41:983-8. [PMID: 19058025 DOI: 10.1007/s11255-008-9509-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 249 |
Matias PJ, Ferreira C, Jorge C, Borges M, Aires I, Amaral T, Gil C, Cortez J, Ferreira A. 25-Hydroxyvitamin D3, arterial calcifications and cardiovascular risk markers in haemodialysis patients. Nephrology Dialysis Transplantation 2008;24:611-8. [DOI: 10.1093/ndt/gfn502] [Cited by in Crossref: 66] [Cited by in F6Publishing: 69] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 250 |
Carter JL, O'riordan SE, Eaglestone GL, Delaney MP, Lamb EJ. Bone mineral metabolism and its relationship to kidney disease in a residential care home population: a cross-sectional study. Nephrology Dialysis Transplantation 2008;23:3554-65. [DOI: 10.1093/ndt/gfn302] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 251 |
Diez GJR, Fassi J, Crucelequi S, Nuñez HR, Trillini M, Furci A, Algranati S, Plantalech L. 25-Hydroxy Vitamin D Levels in Hemodialysis-Requiring End-Stage Renal Disease Patients. Dial Transplant 2008;37:388-390. [DOI: 10.1002/dat.20260] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 252 |
Menon S, Valentini RP, Hidalgo G, Peschansky L, Mattoo TK. Vitamin D insufficiency and hyperparathyroidism in children with chronic kidney disease. Pediatr Nephrol 2008;23:1831-6. [PMID: 18575896 DOI: 10.1007/s00467-008-0842-x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 50] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 253 |
Cuppari L, Carvalho AB, Draibe SA. Vitamin D Status of Chronic Kidney Disease Patients Living in a Sunny Country. Journal of Renal Nutrition 2008;18:408-14. [DOI: 10.1053/j.jrn.2008.05.004] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 254 |
Bossola M, Tazza L, Vulpio C, Luciani G. Reviews: Is Regression of Left Ventricular Hypertrophy in Maintenance Hemodialysis Patients Possible?: LVH IN MAINTENANCE HEMODIALYSIS. Seminars in Dialysis 2008;21:422-30. [DOI: 10.1111/j.1525-139x.2008.00471.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 255 |
Goodman WG, Quarles L. Development and progression of secondary hyperparathyroidism in chronic kidney disease: lessons from molecular genetics. Kidney International 2008;74:276-88. [DOI: 10.1038/sj.ki.5002287] [Cited by in Crossref: 121] [Cited by in F6Publishing: 126] [Article Influence: 8.1] [Reference Citation Analysis]
|
| 256 |
Pai AB, Conner TA. Oxidative Stress and Inflammation in Chronic Kidney Disease: Role of Intravenous Iron and Vitamin D. Journal of Pharmacy Practice 2008;21:214-224. [DOI: 10.1177/0897190008316288] [Reference Citation Analysis]
|
| 257 |
Wang AY, Lam CW, Sanderson JE, Wang M, Chan IH, Lui SF, Sea MM, Woo J. Serum 25-hydroxyvitamin D status and cardiovascular outcomes in chronic peritoneal dialysis patients: a 3-y prospective cohort study. Am J Clin Nutr 2008;87:1631-8. [PMID: 18541550 DOI: 10.1093/ajcn/87.6.1631] [Cited by in Crossref: 99] [Cited by in F6Publishing: 105] [Article Influence: 6.6] [Reference Citation Analysis]
|
| 258 |
Al-Badr W, Martin KJ. Vitamin D and kidney disease. Clin J Am Soc Nephrol 2008;3:1555-60. [PMID: 18450926 DOI: 10.2215/CJN.01150308] [Cited by in Crossref: 107] [Cited by in F6Publishing: 117] [Article Influence: 7.1] [Reference Citation Analysis]
|
| 259 |
Ewers B, Gasbjerg A, Zerahn B, Marckmann P. Impact of Vitamin D Status and Obesity on C-Reactive Protein in Kidney-Transplant Patients. Journal of Renal Nutrition 2008;18:294-300. [DOI: 10.1053/j.jrn.2007.11.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 260 |
Mehrotra R, Kermah D, Budoff M, Salusky IB, Mao SS, Gao YL, Takasu J, Adler S, Norris K. Hypovitaminosis D in chronic kidney disease. Clin J Am Soc Nephrol. 2008;3:1144-1151. [PMID: 18417740 DOI: 10.2215/cjn.05781207] [Cited by in Crossref: 121] [Cited by in F6Publishing: 128] [Article Influence: 8.1] [Reference Citation Analysis]
|
| 261 |
Danziger J. The bone-renal axis in early chronic kidney disease: an emerging paradigm. Nephrology Dialysis Transplantation 2008;23:2733-7. [DOI: 10.1093/ndt/gfn260] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 262 |
Moe SM. Chronic Kidney Disease – Mineral Bone Disorder. Perit Dial Int 2008;28:5-10. [DOI: 10.1177/089686080802802s02] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 263 |
Ewers B, Gasbjerg A, Moelgaard C, Frederiksen AM, Marckmann P. Vitamin D status in kidney transplant patients: need for intensified routine supplementation. Am J Clin Nutr 2008;87:431-7. [PMID: 18258635 DOI: 10.1093/ajcn/87.2.431] [Cited by in Crossref: 57] [Cited by in F6Publishing: 61] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 264 |
Isakova T, Gutierrez O, Shah A, Castaldo L, Holmes J, Lee H, Wolf M. Postprandial mineral metabolism and secondary hyperparathyroidism in early CKD. J Am Soc Nephrol 2008;19:615-23. [PMID: 18216315 DOI: 10.1681/ASN.2007060673] [Cited by in Crossref: 123] [Cited by in F6Publishing: 126] [Article Influence: 8.2] [Reference Citation Analysis]
|
| 265 |
Brancaccio D, Bommer J, Coyne D. Vitamin D receptor activator selectivity in the treatment of secondary hyperparathyroidism: understanding the differences among therapies. Drugs 2007;67:1981-98. [PMID: 17883283 DOI: 10.2165/00003495-200767140-00002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 266 |
Jones G. Vitamin D and Analogues. Principles of Bone Biology. Elsevier; 2008. pp. 1777-99. [DOI: 10.1016/b978-0-12-373884-4.00087-2] [Cited by in Crossref: 4] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 267 |
Ringhofer B, Quarles LD. Management of Calcium and Bone Disease in Renal Patients. Seldin and Giebisch's The Kidney 2008. [DOI: 10.1016/b978-012088488-9.50097-8] [Reference Citation Analysis]
|
| 268 |
Moe SM. Vitamin D, cardiovascular disease, and survival in dialysis patients. J Bone Miner Res 2007;22 Suppl 2:V95-9. [PMID: 18290731 DOI: 10.1359/jbmr.07s218] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 269 |
Gal-Moscovici A, Sprague SM. Role of vitamin D deficiency in chronic kidney disease. J Bone Miner Res 2007;22 Suppl 2:V91-4. [PMID: 18290730 DOI: 10.1359/jbmr.07s203] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 270 |
Jones G. Expanding role for vitamin D in chronic kidney disease: importance of blood 25-OH-D levels and extra-renal 1alpha-hydroxylase in the classical and nonclassical actions of 1alpha,25-dihydroxyvitamin D(3). Semin Dial 2007;20:316-24. [PMID: 17635821 DOI: 10.1111/j.1525-139X.2007.00302.x] [Cited by in Crossref: 124] [Cited by in F6Publishing: 126] [Article Influence: 7.8] [Reference Citation Analysis]
|
| 271 |
Zehnder D, Landray MJ, Wheeler DC, Fraser W, Blackwell L, Nuttall S, Hughes SV, Townend J, Ferro C, Baigent C, Hewison M. Cross-sectional analysis of abnormalities of mineral homeostasis, vitamin D and parathyroid hormone in a cohort of pre-dialysis patients. The chronic renal impairment in Birmingham (CRIB) study. Nephron Clin Pract 2007;107:c109-16. [PMID: 17890873 DOI: 10.1159/000108652] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 272 |
Wolf M, Shah A, Gutierrez O, Ankers E, Monroy M, Tamez H, Steele D, Chang Y, Camargo CA Jr, Tonelli M, Thadhani R. Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int 2007;72:1004-13. [PMID: 17687259 DOI: 10.1038/sj.ki.5002451] [Cited by in Crossref: 586] [Cited by in F6Publishing: 627] [Article Influence: 36.6] [Reference Citation Analysis]
|
| 273 |
Valle ED, Negri AL, Aguirre C, Fradinger E, Zanchetta JR. Prevalence of 25(OH) vitamin D insufficiency and deficiency in chronic kidney disease stage 5 patients on hemodialysis. Hemodialysis Int 2007;11:315-21. [DOI: 10.1111/j.1542-4758.2007.00186.x] [Cited by in Crossref: 76] [Cited by in F6Publishing: 80] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 274 |
Al-Aly Z, Qazi RA, González EA, Zeringue A, Martin KJ. Changes in serum 25-hydroxyvitamin D and plasma intact PTH levels following treatment with ergocalciferol in patients with CKD. Am J Kidney Dis 2007;50:59-68. [PMID: 17591525 DOI: 10.1053/j.ajkd.2007.04.010] [Cited by in Crossref: 123] [Cited by in F6Publishing: 126] [Article Influence: 7.7] [Reference Citation Analysis]
|
| 275 |
Nessim S, Jassal S, Fung S, Chan C. Conversion from conventional to nocturnal hemodialysis improves vitamin D levels. Kidney International 2007;71:1172-6. [DOI: 10.1038/sj.ki.5002228] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 276 |
Microvascular Complications. Endocrine Practice 2007;13:50-55. [DOI: 10.1016/s1530-891x(20)46427-4] [Reference Citation Analysis]
|
| 277 |
Kalantar-zadeh K, Salusky I, Kopple J. Response to ‘Osteodystrophy and dialysis survival’. Kidney International 2007;71:953-954. [DOI: 10.1038/sj.ki.5002219] [Reference Citation Analysis]
|
| 278 |
Elder GJ. Vitamin D levels, bone turnover and bone mineral density show seasonal variation in patients with chronic kidney disease stage 5. Nephrology (Carlton) 2007;12:90-4. [PMID: 17295667 DOI: 10.1111/j.1440-1797.2006.00754.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 12] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 279 |
Cheng S, Coyne D. Vitamin D and outcomes in chronic kidney disease. Curr Opin Nephrol Hypertens 2007;16:77-82. [PMID: 17293681 DOI: 10.1097/MNH.0b013e32802ef494] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 280 |
Hernandez JD, Wesseling K, Boechat MI, Gales B, Salusky IB. Osteomalacia in a hemodialysis patient receiving an active vitamin D sterol. Nat Rev Nephrol 2007;3:227-32. [DOI: 10.1038/ncpneph0443] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 281 |
Mansour J, Shahapuni I, Mailliez S, Aghai R, Fournier A. Optimal paricalcitol starting dose for parathyroid hormone suppression in secondary hyperparathyroidism. Nat Rev Nephrol 2007;3:E2-E2. [DOI: 10.1038/ncpneph0442] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 282 |
Khan S. Vitamin D Deficiency and Secondary Hyperparathyroidism Among Patients with Chronic Kidney Disease. The American Journal of the Medical Sciences 2007;333:201-7. [DOI: 10.1097/maj.0b013e31803bb129] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 283 |
Amin H, Wall BM, Cooke CR. Osteomalacia and secondary hyperparathyroidism after kidney transplantation: Relationship to vitamin D deficiency. Am J Med Sci. 2007;333:58-62. [PMID: 17220696 DOI: 10.1097/00000441-200701000-00009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 284 |
Taskapan H, Wei M, Oreopoulos DG. 25(OH) vitamin D3 in patients with chronic kidney disease and those on dialysis: rediscovering its importance. Int Urol Nephrol 2006;38:323-9. [PMID: 16868705 DOI: 10.1007/s11255-006-0081-7] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 285 |
Martin KJ, González EA. Metabolic Bone Disease in Chronic Kidney Disease. JASN 2007;18:875-85. [DOI: 10.1681/asn.2006070771] [Cited by in Crossref: 131] [Cited by in F6Publishing: 144] [Article Influence: 8.2] [Reference Citation Analysis]
|
| 286 |
London GM, Guérin AP, Verbeke FH, Pannier B, Boutouyrie P, Marchais SJ, Mëtivier F. Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency. J Am Soc Nephrol. 2007;18:613-620. [PMID: 17202417 DOI: 10.1681/asn.2006060573] [Cited by in Crossref: 317] [Cited by in F6Publishing: 333] [Article Influence: 19.8] [Reference Citation Analysis]
|
| 287 |
El-Abbadi M, Giachelli CM. Mechanisms of vascular calcification. Adv Chronic Kidney Dis 2007;14:54-66. [PMID: 17200044 DOI: 10.1053/j.ackd.2006.10.007] [Cited by in Crossref: 67] [Cited by in F6Publishing: 70] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 288 |
Moe SM, Drüeke T, Lameire N, Eknoyan G. Chronic kidney disease-mineral-bone disorder: a new paradigm. Adv Chronic Kidney Dis 2007;14:3-12. [PMID: 17200038 DOI: 10.1053/j.ackd.2006.10.005] [Cited by in Crossref: 169] [Cited by in F6Publishing: 180] [Article Influence: 10.6] [Reference Citation Analysis]
|
| 289 |
Fadem SZ, Moe SM. Management of chronic kidney disease mineral-bone disorder. Adv Chronic Kidney Dis 2007;14:44-53. [PMID: 17200043 DOI: 10.1053/j.ackd.2006.10.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 290 |
Thadhani R, Wolf M. Vitamin D in patients with kidney disease: cautiously optimistic. Adv Chronic Kidney Dis 2007;14:22-6. [PMID: 17200040 DOI: 10.1053/j.ackd.2006.10.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 291 |
Goodman W. Perspectives on renal bone disease. Kidney International 2006;70:S59-63. [DOI: 10.1038/sj.ki.5001980] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 292 |
Cunningham J. Pathogenesis and Prevention of Bone Loss in Patients Who Have Kidney Disease and Receive Long-Term Immunosuppression. JASN 2006;18:223-34. [DOI: 10.1681/asn.2006050427] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 293 |
Levin A, Bakris GL, Molitch M, Smulders M, Tian J, Williams LA, Andress DL. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int. 2007;71:31-38. [PMID: 17091124 DOI: 10.1038/sj.ki.5002009] [Cited by in Crossref: 1008] [Cited by in F6Publishing: 1054] [Article Influence: 59.3] [Reference Citation Analysis]
|
| 294 |
Tan X, Li Y, Liu Y. Paricalcitol attenuates renal interstitial fibrosis in obstructive nephropathy. J Am Soc Nephrol. 2006;17:3382-3393. [PMID: 17082242 DOI: 10.1681/asn.2006050520] [Cited by in Crossref: 211] [Cited by in F6Publishing: 219] [Article Influence: 12.4] [Reference Citation Analysis]
|
| 295 |
Elder GJ, Mackun K. 25-Hydroxyvitamin D deficiency and diabetes predict reduced BMD in patients with chronic kidney disease. J Bone Miner Res 2006;21:1778-84. [PMID: 17002574 DOI: 10.1359/jbmr.060803] [Cited by in Crossref: 69] [Cited by in F6Publishing: 73] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 296 |
Chonchol M, Scragg R. 25-Hydroxyvitamin D, insulin resistance, and kidney function in the Third National Health and Nutrition Examination Survey. Kidney Int. 2007;71:134-139. [PMID: 17082756 DOI: 10.1038/sj.ki.5002002] [Cited by in Crossref: 178] [Cited by in F6Publishing: 189] [Article Influence: 10.5] [Reference Citation Analysis]
|
| 297 |
Kopyt N. Chronic Kidney Disease. Comprehensive Management of High Risk Cardiovascular Patients 2006. [DOI: 10.3109/9781420019667.013] [Reference Citation Analysis]
|
| 298 |
Sakkas GK, Kent-Braun JA, Doyle JW, Shubert T, Gordon P, Johansen KL. Effect of diabetes mellitus on muscle size and strength in patients receiving dialysis therapy. Am J Kidney Dis 2006;47:862-9. [PMID: 16632026 DOI: 10.1053/j.ajkd.2006.01.013] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 299 |
Abboud H, Coyne D, Smolenski O, Anger M, Lunde N, Qiu P, Hippensteel R, Pradhan RS, Palaparthy RV, Kavanaugh A, Melnick JZ, Williams LA, Batlle D. A comparison of dosing regimens of paricalcitol capsule for the treatment of secondary hyperparathyroidism in CKD stages 3 and 4. Am J Nephrol 2006;26:105-14. [PMID: 16543714 DOI: 10.1159/000092033] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 300 |
Mehrotra R. Disordered Mineral Metabolism and Vascular Calcification in Nondialyzed Chronic Kidney Disease Patients. Journal of Renal Nutrition 2006;16:100-18. [DOI: 10.1053/j.jrn.2006.01.006] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 301 |
Coyne D, Acharya M, Qiu P, Abboud H, Batlle D, Rosansky S, Fadem S, Levine B, Williams L, Andress DL, Sprague SM. Paricalcitol capsule for the treatment of secondary hyperparathyroidism in stages 3 and 4 CKD. Am J Kidney Dis 2006;47:263-76. [PMID: 16431255 DOI: 10.1053/j.ajkd.2005.10.007] [Cited by in Crossref: 156] [Cited by in F6Publishing: 161] [Article Influence: 9.2] [Reference Citation Analysis]
|
| 302 |
Levin A, Li YC. Vitamin D and its analogues: do they protect against cardiovascular disease in patients with kidney disease? Kidney Int. 2005;68:1973-1981. [PMID: 16221197 DOI: 10.1111/j.1523-1755.2005.00651.x] [Cited by in Crossref: 121] [Cited by in F6Publishing: 127] [Article Influence: 7.1] [Reference Citation Analysis]
|
| 303 |
Block GA. Opinion: How Should Chronic Medical Therapies be Altered with the Onset of End-Stage Renal Disease and Initiation of Dialysis? Seminars in Dialysis 2006;19:13-16. [DOI: 10.1111/j.1525-139x.2006.00113.x] [Reference Citation Analysis]
|
| 304 |
González EA, Aly ZA, Martin KJ. Assessment of Bone and Joint Diseases: Renal Osteodystrophy. Dynamics of Bone and Cartilage Metabolism 2006. [DOI: 10.1016/b978-012088562-6/50046-7] [Reference Citation Analysis]
|
| 305 |
Andress D. Vitamin D in chronic kidney disease: A systemic role for selective vitamin D receptor activation. Kidney International 2006;69:33-43. [DOI: 10.1038/sj.ki.5000045] [Cited by in Crossref: 220] [Cited by in F6Publishing: 224] [Article Influence: 12.9] [Reference Citation Analysis]
|
| 306 |
Andress DL. Vitamin D treatment in chronic kidney disease. Semin Dial 2005;18:315-21. [PMID: 16076355 DOI: 10.1111/j.1525-139X.2005.18408.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 307 |
Thierry-Palmer M, Cephas S, Sayavongsa P, Doherty A, Arnaud SB. Dahl salt-sensitive rats develop hypovitaminosis D and hyperparathyroidism when fed a standard diet. Bone 2005;36:645-53. [PMID: 15784187 DOI: 10.1016/j.bone.2005.01.016] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 308 |
Wood C, González EA, Martin KJ. Challenges in the therapy of secondary hyperparathyroidism. Ther Apher Dial 2005;9:4-8. [PMID: 15828898 DOI: 10.1111/j.1774-9987.2005.00208.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 309 |
Langman CB. Renal osteodystrophy: A pediatric perspective, 2005. Growth Hormone & IGF Research 2005;15:42-7. [DOI: 10.1016/j.ghir.2005.06.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 310 |
González EA, Al-aly Z, Martin KJ. Difficulties in Achieving the K/DOQI Practice Guidelines for Bone and Mineral Metabolism: DIFFICULTIES IN ACHIEVING THE K-DOQI PRACTICE GUIDELINES. Seminars in Dialysis 2005;18:171-4. [DOI: 10.1111/j.1525-139x.2005.18302.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 311 |
Gutierrez O, Isakova T, Rhee E, Shah A, Holmes J, Collerone G, Jüppner H, Wolf M. Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease. J Am Soc Nephrol. 2005;16:2205-2215. [PMID: 15917335 DOI: 10.1681/asn.2005010052] [Cited by in Crossref: 663] [Cited by in F6Publishing: 693] [Article Influence: 36.8] [Reference Citation Analysis]
|
